OneSkin

Finding molecules able to reverse skin aging

OneSkin is active in the consumer bio space based in North America, founded in 2016.

Profile

OneSkin aims to promote skin rejuvenation by decoding the aging process. By replicating skin aging using 3D models and correlating biological markers with chronological age, we have created an efficient engine to screen new anti-aging molecules. We are the first-in-class platform to quantitatively measure the rejuvenation effect on any molecule in human tissues.

OneSkin is positioned in consumer bio, a segment that rewards a clear, focused offering.

Its base of operations is North America.

The company is listed at the SOSV portfolio company stage of development.

Recorded headcount: 2-10 employees.

It has disclosed roughly $5K in funding.

Website: oneskin.co